Download PDF
Thromb Haemost 2008; 99(04): 796-797
DOI: 10.1160/TH07-11-0708
Letters to the Editor
Schattauer GmbH

Preventing venous thromboembolism in US hospitals: Are surgical patients receiving appropriate prophylaxis?

Alpesh N. Amin
1   School of Medicine, University of California-Irvine, Irvine, California, USA
,
Stephen Stemkowski
2   Premier Inc, Charlotte, North Carolina, USA
,
Jay Lin
3   sanofi-aventis, Bridgewater, New Jersey, USA
,
Guiping Yang
2   Premier Inc, Charlotte, North Carolina, USA
› Author AffiliationsFinancial support: Financial and editorial support for this publication was provided by sanofi-aventis US Inc. However the authors were fully responsible for content and editorial decisions for this manuscript. Alpesh Amin is a research consultant and is on the speaker’s bureau for sanofi-aventis US Inc. Stephen Stemkowski and Guiping Yang work for Premier Inc, who received funding to carry out this work from sanofi-aventis US Inc. Jay Lin is an employee of sanofi-aventis US Inc.
Further Information

Publication History

Received: 30 November 2007

Accepted after major revision: 27 February 2008

Publication Date:
25 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Geerts WH, Heit JA, Clagett GP. et al. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl. 01) 132S-175S.
    CrossrefPubMedGoogle Scholar
  • 2 Heit JA, Cohen AT, Anderson FA. Jr on behalf of the VTE Impact Assessment Group. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism events (VTE) in the US. Blood (ASH Annual Meeting Abstracts) 2005; 106 Abstract 910.
    PubMedGoogle Scholar
  • 3 Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest 2001; 120: 1964-1971.
    CrossrefPubMedGoogle Scholar
  • 4 Vallano A, Arnau JM, Miralda GP. et al. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J 2004; 2: 3.
    CrossrefPubMedGoogle Scholar
  • 5 Goldhaber SZ, Tapson VF. DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004; 93: 259-262.
    CrossrefPubMedGoogle Scholar
  • 6 Tapson VF, Hyers TM. et al. ; NABOR (National Anticoagulation Benchmark and Outcomes Report) Steering Committee. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med 2005; 165: 1458-1464.
    CrossrefPubMedGoogle Scholar
  • 7 Cohen AT, Tapson VF, Bergmann JF. et al. ; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008; 371: 387-394.
    CrossrefPubMedGoogle Scholar
  • 8 Medicare Quality Improvement Committee. SCIP Project Information. Available at www.medqic.org/scip/ Accessed October 8, 2007.
    PubMed
  • 9 Joint Commission Performance Measurement Initiatives National Consensus Standards for Prevention and Care of Venous Thromboembolism (VTE) – Last Updated 5/7/07 Available at http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htm Accessed October 11, 2007.
    PubMed
  • 10 Stratton MA, Anderson FA, Bussey HI. et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 2000; 160: 334-340.
    CrossrefPubMedGoogle Scholar
  • 11 Friedman R, Gallus A, Cushner F. et al. Compliance with ACCP guidelines for prevention of venous thromboembolism: multinational findings from the Global Orthopaedic Registry (GLORY). Blood 2003; 102 Abstract 574.
    PubMedGoogle Scholar
  • 12 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 338S-400S.
    CrossrefPubMedGoogle Scholar